Activity Provided By:

i3 Health

Oncology Nursing Showdown! Aggressive Non–Hodgkin Lymphoma Edition: Module 1 - Diffuse Large B-Cell Lymphoma

Overview / Abstract:	In the first segment of this three-part series, Maria Badillo, MSN, RN, OCN®, CCRP, Research Nurse Manager, MD Anderson Cancer Center, evaluates guideline recommendations for the management of patients with advanced diffuse large B-cell lymphoma (DLBCL). Learners will receive expert insight on assessing emerging data on novel therapies, strategies to manage adverse events, and optimizing treatment for patients with advanced DLBCL. Complete modules 2 and 3 for more in-depth knowledge of aggressive non-Hodgkin lymphoma. Start now!
Expiration	May 12, 2022
Discipline(s)	Nurse Practitioner , Nursing CNE
Format	Webinar / Webcast / Video
Credits / Hours	0.5 NCPD \| 0.3 pharmacotherapy content for APRNs
Accreditation	ANCC
Presenters / Authors / Faculty	Maria Badillo, MSN, RN, OCN®, CCRP Research Nurse Manager MD Anderson Cancer Center
Sponsors / Supporters / Grant Providers	This activity is supported by independent educational grants from Pharmacyclics LLC (an Abbvie Company), Janssen Biotech, Inc. and Seagen, Inc.
Keywords / Search Terms	i3 Health i3 health, non-hogkin lymphoma, lymphoma, DLBCL, diffuse large b-cerll lymphoma, NCPD, free NCPD, online NCPD, online NCPD CME Free CE CME Free CE CME Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map